Controversies in the management of gastrointestinal stromal tumors.

Item

http://www.wikidata.org/entity/Q38199797

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Controversies in the management of gastrointestinal stromal tumors.

@en

type

Item

label

Controversies in the management of gastrointestinal stromal tumors.

@en

prefLabel

Controversies in the management of gastrointestinal stromal tumors.

@en

P1476

Controversies in the management of gastrointestinal stromal tumors.

@en

P2093

Andrew P Barbour

http://www.w3.org/2001/XMLSchema#string

Dusan Kotasek

http://www.w3.org/2001/XMLSchema#string

Grant McArthur

http://www.w3.org/2001/XMLSchema#string

John Zalcberg

http://www.w3.org/2001/XMLSchema#string

Stephen Ackland

http://www.w3.org/2001/XMLSchema#string

P2860

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors.

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.

Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.

Drug transporters and imatinib treatment: implications for clinical practice.

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Adjuvant treatment of GIST: patient selection and treatment strategies.

P304

216-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12187

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261182761

http://www.w3.org/2001/XMLSchema#string

P698

24673914

http://www.w3.org/2001/XMLSchema#string